Incyte Corporation (INCY)
NASDAQ·Healthcare·Biotechnology
$116.97
+0.32%
Mkt Cap $23.64B
Analyst Ratings
Buy
19
Hold
7
Sell
0
Price Target (72 analysts)
$130.07
Range $104.00 – $155.00
Implied Upside
+11.2%
Consensus $130.07 vs current $116.97
NASDAQ·Healthcare·Biotechnology
$116.97
+0.32%
Mkt Cap $23.64B
Buy
19
Hold
7
Sell
0
Price Target (72 analysts)
$130.07
Range $104.00 – $155.00
+11.2%
Consensus $130.07 vs current $116.97